Achieving Safe Use While Improving Patient Care
Return to EP/LA Opioid REMS home.
Launch date: December 6, 2013
Estimated time to complete session: 4 hours
This AAFP CME session will focus on the safe prescribing of ER/LA opioid analgesics and includes all six components of the FDA Blueprint. It will take approximately 4 hours to complete. Once all components are completed learners will be awarded 4 CME credits and defined as a “completer” of the REMS CME activity for ER/LA opioids.
Enhance your patient care today and earn 2 additional AAFP Prescribed credits when you complete the Translation to Practice™ (t2p) process. Exclusively for AAFP members.
Don’t have time to complete this activity in one sitting? Bookmark the activity and come back later. The system will save the place you left off.
1. Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy, as well as possible misuse.
2. Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques as well as appropriate discontinuation strategies.
3. Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects.
4. Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
5. Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids.
View technical requirements (opens in a new window).
View CME Credit Information (opens in a new window).
View AAFP Staff (opens in a new window).
View Disclosures and Disclaimers (opens in a new window).
© 2013 American Academy of Family Physicians.
Webcasts - FDA BLUEPRINT UNITS 1-5 and REMS IN PRACTICE FOR FAMILY PHYSICIANS
L. Paul Gianutsos, MD, MPH, FAAFP
Dr. Gianutsos received his undergraduate degree at the University of California Berkeley and his Master of Public Health in epidemiology and medical degrees at UCLA. He completed Family Medicine residency training at Providence Family Medicine in Seattle. He is certified in Family Medicine and Addiction Medicine and is currently the Interim Program Director at Swedish Family Medicine Residency Cherry Hill in Seattle.
CME Bulletin - FDA BLUEPRINT UNIT 6
Barry D. Weiss, MD, FAAFP
Dr. Weiss is a professor of Family and Community Medicine at the University of Arizona College of Medicine, Tucson. He is the medical editor for FP Essentials and associate editor for American Family Physician. He has authored nearly 150 journal articles and several medical textbooks.
- 4.00 AAFP prescribed